Abstract
Medullary thyroid cancer is relatively rare and accounts for approximately 2% of all thyroid cancer diagnoses in the United States. However, in general it is a more aggressive cancer than the more common papillary thyroid cancer. The more aggressive nature of medullary thyroid cancer leads to a different treatment algorithm relative to papillary thyroid cancer. The primary treatment for medullary thyroid cancer is total thyroidectomy with central neck dissection. This is almost universally accepted as standard of care across the world with minimal controversy. However, significant controversy remains regarding the optimal algorithm for surgical management of the lateral neck lymph nodes. This chapter reviews the most recent evidence regarding how to manage the lateral neck lymph nodes in medullary thyroid cancer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wells SA, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25:567–610. https://doi.org/10.1089/thy.2014.0335.
Machens A, Ukkat J, Hauptmann S, Dralle H. Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg. 2007;142:289–93.; discussion 294. https://doi.org/10.1001/archsurg.142.3.289.
Randle RW, Balentine CJ, Leverson GE, et al. Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery. 2017;161:137–46. https://doi.org/10.1016/j.surg.2016.04.053.
Torresan F, Cavedon E, Mian C, Iacobone M. Long-term outcome after surgery for medullary thyroid carcinoma: a single-center experience. World J Surg. 2018;42:367–75. https://doi.org/10.1007/s00268-017-4321-z.
Adam MA, Thomas S, Roman SA, et al. Rethinking the current American Joint Committee on cancer TNM staging system for medullary thyroid cancer. JAMA Surg. 2017;152:869–76. https://doi.org/10.1001/jamasurg.2017.1665.
Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d’étude des tumeurs à calcitonine. Clin Endocrinol. 1998;48:265–73.
Siironen P, Hagström J, Mäenpää HO, et al. Lymph node metastases and elevated postoperative calcitonin: predictors of poor survival in medullary thyroid carcinoma. Acta Oncol. 2016;55:357–64. https://doi.org/10.3109/0284186X.2015.1070963.
Machens A, Dralle H. Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2655–63. https://doi.org/10.1210/jc.2009-2368.
Machens A, Hauptmann S, Dralle H. Prediction of lateral lymph node metastases in medullary thyroid cancer. Br J Surg. 2008;95:586–91. https://doi.org/10.1002/bjs.6075.
Leggett MD, Chen SL, Schneider PD, Martinez SR. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma. Ann Surg Oncol. 2008;15:2493–9. https://doi.org/10.1245/s10434-008-0022-z.
Machens A, Dralle H. Prognostic impact of N staging in 715 medullary thyroid cancer patients: proposal for a revised staging system. Ann Surg. 2013;257:323–9. https://doi.org/10.1097/SLA.0b013e318268301d.
Polistena A, Monacelli M, Lucchini R, et al. Surgical morbidity of cervical lymphadenectomy for thyroid cancer: a retrospective cohort study over 25 years. Int J Surg. 2015;21:128–34. https://doi.org/10.1016/j.ijsu.2015.07.698.
Glenn JA, Yen TWF, Fareau GG, et al. Institutional experience with lateral neck dissections for thyroid cancer. Surgery. 2015;158:972–8.; discussion 978. https://doi.org/10.1016/j.surg.2015.03.066.
Gane EM, McPhail SM, Hatton AL, et al. The relationship between physical impairments, quality of life and disability of the neck and upper limb in patients following neck dissection. J Cancer Surviv. 2018; https://doi.org/10.1007/s11764-018-0697-5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Grogan, R.H. (2019). Management of the Clinically Negative Lateral Neck in Medullary Thyroid Cancer. In: Gooi, Z., Agrawal, N. (eds) Difficult Decisions in Head and Neck Oncologic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-15123-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-15123-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15122-5
Online ISBN: 978-3-030-15123-2
eBook Packages: MedicineMedicine (R0)